Deerfield Private Design Fund IV, L.P.
SEC-identified person · CIK 1680307 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zafgen, INC. ZFGN | Director | filed 2020 - 2026 |
| Nuvalent, Inc. NUVL | Director | filed 2021 - 2025 |
| Silverback Therapeutics, Inc. SPRY | Director | filed 2022 - 2025 |
| DFB Healthcare Acquisitions Corp. DFBH | Director | filed 2018 - 2024 |
| Mirum Pharmaceuticals, Inc. MIRM | Officer | filed 2019 - 2022 |
| Oncology Institute, Inc. TOI | Director | filed 2020 - 2021 |
| Singular Genomics Systems, Inc. OMIC | Officer | filed 2021 - 2021 |
| Edgewise Therapeutics, Inc. EWTX | Officer | filed 2021 - 2021 |
| Annexon, Inc. ANNX | Officer | filed 2020 - 2020 |
| Nkarta, Inc. NKTX | Officer | filed 2020 - 2020 |
| Revolution Medicines, Inc. RVMD | Officer | filed 2020 - 2020 |
| Schrodinger, Inc. SDGR | Officer | filed 2020 - 2020 |
| Cabaletta Bio, Inc. CABA | Officer | filed 2019 - 2019 |
| Korro Bio, Inc. KRRO | Officer | filed 2019 - 2019 |
| Arvinas, INC. AVRN | Officer | filed 2018 - 2018 |
| Protara Therapeutics, Inc. TARA | Director | filed 2017 - 2017 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.